Loading company…
Shanghai-based biopharmaceutical company offering CDMO services for macromolecular drugs and developing mammalian cell culture media.
Founded in 2017 and based in Shanghai, China, ZhenGe Biotech provides contract development and manufacturing services for macromolecular biopharmaceuticals, including cell line development, process development, pilot and clinical sample production and commercial CMO work. It also develops and produces mammalian cell culture media. The company completed USD 55 million of series A financing in March 2020 and series B financing in February 2021, and its listed stage is Series C.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in